Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomised, Placebo-controlled, Phase II Study to Evaluate ProCervix Efficacy to Clear HPV 16 and HPV 18 Infection in Women With Normal Cytology or ASCUS/LSIL

NCT01957878 is registered in ClinicalTrials.gov with Genticel as lead sponsor.

NCT NCT01957878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01957878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomised, Placebo-controlled, Phase II Study to Evaluate ProCervix Efficacy to Clear HPV 16 and HPV 18 Infection in Women With Normal Cytology or ASCUS/LSIL
Lead sponsor
Genticel
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
October 31, 2016
Enrollment
239 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

genital infection viral, human papilloma virus